Skip to main content
Fig. 5 | EJNMMI Research

Fig. 5

From: Radioimmunotherapy of prostate cancer targeting human kallikrein-related peptidase 2

Fig. 5

Survival and weight. a Kaplan-Meier. Survival over time, median survival was 45 days for NaCl, 38 days for non-specific IgG, 35 days for 30 μg m11B6, and 88 days for 10 MBq of 177Lu-m11B6. For the two remaining groups there is no median survival available since only one mouse where sacrificed within 120 days due to too large tumor volume. b Animal weight after treatment with 177Lu-m11B6, no change is seen. c Animal weight in control groups, a drop in the weights of some animals were seen, especially in the group given non-specific IgG

Back to article page